Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1995

Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85(2):552-65.

Klampfer L, Chen-Kiang S, Vilcek J. Activation of the TSG-6 gene by NF-IL6 requires two adjacent NF-IL6 binding sites. J Biol Chem. 1995;270(8):3677-82.

Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G, et al. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene. 1995;11(4):647-52.

Gordon FD, Anastopoulos H, Khettry U, Loda M, Jenkins RL, Lewis WD, et al. Hepatitis C infection: a rare cause of fulminant hepatic failure. Am J Gastroenterol. 1995;90(1):117-20.

Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol. 1995;34(3):159-65.

Schettino EW, Newcomb EW, Potmesil M, Inghirami G, Casali P. Clonal analysis of IgM+ CD5+ CLL B cells. Ann N Y Acad Sci. 1995;764:485-91.

Magro CM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter's disease. Hum Pathol. 1995;26(6):633-8.

Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, et al. CDC25 phosphatases as potential human oncogenes. Science. 1995;269(5230):1575-7.

Lin J, Gettys TW, Qin L, Chavin KD, Yang Q, Ding Y, et al. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. Pathobiology. 1995;63(4):175-87.

Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, et al. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer. 1995;75(11):2747-56.